A clinical strategy focused on modulating the concentration of Sex Hormone-Binding Globulin (SHBG), a liver-produced glycoprotein that binds and inactivates sex hormones, primarily testosterone and estradiol. Effective management involves therapeutic interventions, often nutritional or pharmacological, designed to raise or lower SHBG levels to optimize the ratio of free (biologically active) to bound hormones. This management is essential for ensuring target tissues receive adequate hormonal signaling.
Origin
The term combines the acronym ‘SHBG,’ which represents the protein’s function, with ‘Management,’ indicating a proactive clinical strategy to control its effects. The importance of SHBG as a key regulator of sex hormone bioavailability was established in the mid-20th century, leading to clinical practices focused on optimizing its concentration.
Mechanism
SHBG management operates by influencing the liver’s synthesis of the protein, which is sensitive to factors like insulin levels, thyroid status, and estrogen exposure. For instance, high insulin and androgens typically suppress SHBG production, increasing free hormone levels. Conversely, oral estrogens and thyroid hormones tend to increase SHBG. The clinical mechanism involves adjusting diet, supplements, or medications to shift these regulatory inputs and achieve the desired balance of free hormones.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.